Fundraising FoxHemi Ventures, Llc — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Persephone Biosciencespersephone.bioinSeed · Feb 2021
Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development.
BiotechConsumerDigital HealthFemTechHealthtechSan Diego, US
Stephen Van Dien(CTO)inStephanie Culler(CEO)in
PartnerAmy Gu· solo GP
Co-investorsFirst Bight VenturesPropel Bio PartnersBioBritFifty YearsOcampo CapitalPioneer+13 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.